Skip to main content
. 2022 May 20;3(5):e221116. doi: 10.1001/jamahealthforum.2022.1116

Figure 3. Projected Absolute Numbers of Medical Resources and Corresponding Mortality Benefits for Specified Screening Strategies.

Figure 3.

Absolute numbers of prostate cancer deaths without screening projected by the 2 models were 9610 (FHCRC) and 13 728 (MISCAN). FHCRC indicates Fred Hutchinson Cancer Research Center; MISCAN, Erasmus Medical Center Microsimulation Screening Analysis; and PSA, prostate-specific antigen.